The content on this site is intended for healthcare professionals only
OncoAlert and ecancer ASCO roundup - Day 2
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
8 Jun 2021
OncoAlert and ecancer ASCO roundup - Day 1
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
8 Jun 2021
Amivantamab in combination with lazertinib for osimertinib-relapsed, chemo-naïve...
Dr Joshua Sabari and Dr Anna Minchom
8 Jun 2021
NIVO plus chemo vs chemo alone as neoadjuvant treatment for patients with resect...
Dr Jonathan Spicer - McGill University, Montreal, Canada
4 Jun 2021
OncoAlert and ecancer weekly roundup for April 26 - May 3, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
7 May 2021
UpSwinG: Real-world, non-interventional cohort study on TKI activity in patients...
Dr Satoru Miura - Niigata Cancer Center Hospital, Niigata, Japan
4 May 2021
PIPSeN trial: Olaparib maintenance vs placebo in platinum-sensitive non-small ce...
Dr Sophie Postel-Vinay - Gustave Roussey Cancer Center, Paris, France
4 May 2021
Efficacy and early discontinuation predictors in NSCLC patients receiving nivolu...
Dr Giulia Pasello - University of Padova, Padua, Italy
4 May 2021
OncoAlert and ecancer weekly roundup for April 19 - 25, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
26 Apr 2021
Language and understanding: The complexity of insight in cancer care
Dr Tianna Martin - Beaumont Hospital, Dublin, Ireland
22 Apr 2021
Understanding patient experience in Europe: The first Global Lung Cancer Coaliti...
Vanessa Beattie - Lung Cancer Nursing UK, Solihull, England
22 Apr 2021
CONVERT trial: Patterns of relapse following thoracic radiotherapy in patients w...
Dr Robin Portner - The Christie NHS Foundation Trust, Manchester, UK
19 Apr 2021
